University of Nairobi   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Nairobi Kenya (1956)

Organization Overview

First Clinical Trial
2003
NCT01371175
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Department of Paediatrics and Child Health, Kenyatta National Hospital, University of Nairobi | Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya | KAVI - Institute of Clinical Research | KAVI-Institute of Clinical Research / University of Nairobi | Kenya AIDS Vaccine Initiative, University of Nairobi | Mbagathi Hospital, Nairobi, Kenya | University of Nairobi | University of Nairobi, P.O Box 19676 00202 Nairobi

Active Ingredients

Drugs in Phase 4 Trials (6)

amlodipine (norvasc) (1 trial)

dolutegravir (tivicay) (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

live attenuated varicella vaccine (1 trial)

perindopril (aceon) (1 trial)

reduced iron (1 trial)

Drugs in Phase 3 Trials (23)

abacavir (ziagen) (2 trials)

amodiaquine (camoquin) (1 trial)

amoxicillin (1 trial)

ampicillin (1 trial)

benzylpenicilloyl polylysine (pre-pen) (1 trial)

bictegravir (Biktarvy) (1 trial)

ceftriaxone (rocephin) (1 trial)

didanosine (videx) (1 trial)

emtricitabine (emtriva) (2 trials)

fish oil (Omegavan) (1 trial)

gentamicin (garamycin) (2 trials)

lamivudine (epivir) (2 trials)

lopinavir (Kaletra) (2 trials)

nevirapine (viramune) (2 trials)

procaine benzylpenicillin (novocaine) (3 trials)

pyrimethamine (daraprim) (1 trial)

ritonavir (Norvir) (2 trials)

soybean oil (1 trial)

stavudine (zerit) (1 trial)

sulfadoxine (1 trial)

tenofovir (viread) (2 trials)

tenofovir alafenamide (genvoya) (1 trial)

zidovudine (retrovir) (3 trials)

Drugs in Phase 2 Trials (7)

ad26.zebov (1 trial)

ad35-grin (1 trial)

dna.hiva (1 trial)

fluconazole (diflucan) (1 trial)

flucytosine (ancobon) (1 trial)

mva.hiva (2 trials)

psg2.hivconsv (1 trial)

Drugs in Phase 1 Trials (4)

chadox1.thivconsv1 (1 trial)

mva.thivconsv3 (1 trial)

mva.thivconsv4 (1 trial)

vrc-hivdna-016-00-vp (1 trial)

Drugs in Other Trials (10)

acetylsalicylic acid (aspirin) (1 trial)

albendazole (Albenza) (1 trial)

calcium (1 trial)

clavulanate (Augmentin) (1 trial)

fentanyl (Innovar) (1 trial)

fluoxetine (prozac) (1 trial)

folic acid (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

iron (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Chickenpox (Phase 4)

Depression (Phase 3)

Herpes Zoster (Phase 4)

HIV Infections (Phase 3)

Hypertension (Phase 4)

Infections (Phase 2)

Malaria (Phase 4)

Malaria, Falciparum (Phase 3)

Malnutrition (Phase 3)

Pneumonia (Phase 3)

Severe Acute Malnutrition (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 27
  • # of Trial APIs: 50